{"pmid":32291542,"title":"The epidemiology and clinical information about COVID-19.","text":["The epidemiology and clinical information about COVID-19.","In December 2019, pneumonia of unknown cause occurred in Wuhan, Hubei Province, China. On 7 January 2020, a novel coronavirus, named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was identified in the throat swab sample of one patient. The World Health Organization (WHO) announced the epidemic disease caused by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). Currently, COVID-19 has spread widely around the world, affecting more than seventy countries. China, with a huge burden of this disease, has taken strong measures to control the spread and improve the curative rate of COVID-19. In this review, we summarized the epidemiological characteristics, clinical features, diagnosis, treatment, and prognosis of COVID-19. A comprehensive understanding will help to control the disease.","Eur J Clin Microbiol Infect Dis","Ge, Huipeng","Wang, Xiufen","Yuan, Xiangning","Xiao, Gong","Wang, Chengzhi","Deng, Tianci","Yuan, Qiongjing","Xiao, Xiangcheng","32291542"],"abstract":["In December 2019, pneumonia of unknown cause occurred in Wuhan, Hubei Province, China. On 7 January 2020, a novel coronavirus, named as severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), was identified in the throat swab sample of one patient. The World Health Organization (WHO) announced the epidemic disease caused by SARS-CoV-2 as coronavirus disease 2019 (COVID-19). Currently, COVID-19 has spread widely around the world, affecting more than seventy countries. China, with a huge burden of this disease, has taken strong measures to control the spread and improve the curative rate of COVID-19. In this review, we summarized the epidemiological characteristics, clinical features, diagnosis, treatment, and prognosis of COVID-19. A comprehensive understanding will help to control the disease."],"journal":"Eur J Clin Microbiol Infect Dis","authors":["Ge, Huipeng","Wang, Xiufen","Yuan, Xiangning","Xiao, Gong","Wang, Chengzhi","Deng, Tianci","Yuan, Qiongjing","Xiao, Xiangcheng"],"date":"2020-04-16T11:00:00Z","year":2020,"_id":"32291542","week":"202016|Apr 13 - Apr 19","doi":"10.1007/s10096-020-03874-z","keywords":["Clinical","Coronavirus disease 2019","Epidemiology","Pathology","Severe acute respiratory syndrome coronavirus-2","Treatment"],"source":"PubMed","topics":["Diagnosis","Treatment"],"weight":1,"locations":["Wuhan","Hubei","China","China"],"countries":["China"],"countries_codes":["CHN|China"],"_version_":1664266295542022144,"score":8.233237,"similar":[{"pmid":32252141,"title":"Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","text":["Epidemiology, virology, and clinical features of severe acute respiratory syndrome -coronavirus-2 (SARS-CoV-2; Coronavirus Disease-19).","A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features.","Clin Exp Pediatr","Park, Su Eun","32252141"],"abstract":["A cluster of severe pneumonia of unknown etiology in Wuhan City, Hubei province in China emerged in December 2019. A novel coronavirus named severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) was isolated from lower respiratory tract sample as the causative agent. The current outbreak of infections with SARS-CoV-2 is termed Coronavirus Disease 2019 (COVID-19) by the World Health Organization (WHO). COVID-19 rapidly spread into at least 114 countries and killed more than 4,000 people by March 11 2020. WHO officially declared COVID-19 a pandemic on March 11, 2020. There have been two novel coronavirus outbreaks in the past two decades. The 2002-2003 outbreak of severe acute respiratory syndrome (SARS) in 2002-2003 caused by SARS-CoV had a case fatality rate of around 10% (8,098 confirmed cases and 774 death), while Middle East respiratory syndrome (MERS) caused by MERS-CoV killed 861 people out of a total 2,502 confirmed cases between 2012 and 2019. The purpose of this review is to summarize known-to-date information about SARS-CoV-2, transmission of SARS-CoV-2, and clinical features."],"journal":"Clin Exp Pediatr","authors":["Park, Su Eun"],"date":"2020-04-07T11:00:00Z","year":2020,"_id":"32252141","week":"202015|Apr 06 - Apr 12","doi":"10.3345/cep.2020.00493","keywords":["COVID-19","MERS-CoV","SARS-CoV","SARS-CoV-2","coronavirus"],"source":"PubMed","locations":["China","Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Transmission","Diagnosis"],"weight":1,"_version_":1663352136196423680,"score":225.89433},{"pmid":32220177,"title":"[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","text":["[Epidemiology, Treatment, and Epidemic Prevention and Control of the Coronavirus Disease 2019: a Review].","This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic.","Sichuan Da Xue Xue Bao Yi Xue Ban","Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group","32220177"],"abstract":["This review summarizes the ongoing researches regarding etiology, epidemiology, transmission dynamics, treatment, and prevention and control strategies of the coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with comparison to severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV) and pandemic H1N1 virus. SARS-CoV-2 may be originated from bats, and the patients and asymptomatic carriers are the source of epidemic infection. The virus can be transmitted human-to-human through droplets and close contact, and people at all ages are susceptible to this virus. The main clinical symptoms of the patients are fever and cough, accompanied with leukocytopenia and lymphocytopenia. Effective drugs have been not yet available thus far. In terms of the prevention and control strategies, vaccine development as the primary prevention should be accelerated. Regarding the secondary prevention, ongoing efforts of the infected patients and close contacts quarantine, mask wearing promotion, regular disinfection in public places should be continued. Meanwhile, rapid detection kit for serological monitoring of the virus in general population is expected so as to achieve early detection, early diagnosis, early isolation and early treatment. In addition, public health education on this disease and prevention should be enhanced so as to mitigate panic and mobilize the public to jointly combat the epidemic."],"journal":"Sichuan Da Xue Xue Bao Yi Xue Ban","authors":["Luan, Rong-Sheng","Wang, Xin","Sun, Xin","Chen, Xing-Shu","Zhou, Tao","Liu, Quan-Hui","Lu, Xin","Wu, Xian-Ping","Gu, Dong-Qing","Tang, Ming-Shuang","Cui, Hui-Jie","Shan, Xue-Feng","Ouyang, Jing","Zhang, Ben","Zhang, Wei","Sichuan University Covid-, Emergency Research Group"],"date":"2020-03-29T11:00:00Z","year":2020,"_id":"32220177","week":"202013|Mar 23 - Mar 29","doi":"10.12182/20200360505","keywords":["Coronavirus disease 2019","Epidemic prevention and control","Epidemiology","Treatment"],"source":"PubMed","topics":["Diagnosis","Treatment","Prevention"],"weight":1,"_version_":1663352135047184384,"score":224.81017},{"pmid":32234465,"pmcid":"PMC7118423","title":"Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","text":["Recent Progress in understanding 2019 Novel Coronavirus associated with Human Respiratory Disease: Detection, Mechanism and Treatment.","Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection.","Int J Antimicrob Agents","Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun","32234465"],"abstract":["Viral respiratory diseases such as the severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), always pose severe threat to people. First identified in the late December 2019, in Wuhan, China, a novel coronavirus (2019-nCoV) has rampantly spread to lots of provinces in China, and multiple countries are affected. The viral outbreaks have stirred panic and emergency on public health around the world and the number of infections continues to rise. But the cause and consequence of the pneumonia still remain unknown. In order to effectively implement the epidemic prevention, early identification and diagnosis is critical to disease control. Herein we scrutinize a series of available studies by global scientists on the clinical manifestations, detection methods and treatment options of 2019 novel coronavirus pneumonia, also propose potential strategies for preventing the infection."],"journal":"Int J Antimicrob Agents","authors":["Kang, Shuntong","Peng, Wenyao","Zhu, Yuhao","Lu, Shiyao","Zhou, Min","Lin, Wei","Wu, Wenfang","Huang, Shu","Jiang, Liping","Luo, Xuan","Deng, Meichun"],"date":"2020-04-03T11:00:00Z","year":2020,"_id":"32234465","week":"202014|Mar 30 - Apr 05","doi":"10.1016/j.ijantimicag.2020.105950","keywords":["Detection","Mechanism","Novel coronavirus","Treatment"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Mechanism","Treatment"],"weight":1,"_version_":1663352135478149120,"score":209.0402},{"pmid":32125126,"title":"[Management and clinical thinking of Coronavirus Disease 2019].","text":["[Management and clinical thinking of Coronavirus Disease 2019].","In December 2019, the 2019 novel coronavirus pneumonia (NCP, officially named Coronavirus Disease 2019(COVID-19) by the World Health Organization) broke out in Wuhan, Hubei, and it quickly spread to the whole country and abroad. The situation was at stake. The sudden and serious COVID-19 epidemic has brought us a lot of urgent problems. How to effectively control the spread of COVID-19? When does the population infection rate rise to its peak? What will eventually be the number of infected patients? How to make early diagnosis? What effective antiviral drugs are available? How to effectively treat with existing drugs? Can it successfully improve the survival rate of critically patients? In response to the above questions, we put forward corresponding suggestions and reflections from the perspective of the infectious clinician.","Zhonghua Gan Zang Bing Za Zhi","Ma, K","Chen, T","Han, M F","Guo, W","Ning, Q","32125126"],"abstract":["In December 2019, the 2019 novel coronavirus pneumonia (NCP, officially named Coronavirus Disease 2019(COVID-19) by the World Health Organization) broke out in Wuhan, Hubei, and it quickly spread to the whole country and abroad. The situation was at stake. The sudden and serious COVID-19 epidemic has brought us a lot of urgent problems. How to effectively control the spread of COVID-19? When does the population infection rate rise to its peak? What will eventually be the number of infected patients? How to make early diagnosis? What effective antiviral drugs are available? How to effectively treat with existing drugs? Can it successfully improve the survival rate of critically patients? In response to the above questions, we put forward corresponding suggestions and reflections from the perspective of the infectious clinician."],"journal":"Zhonghua Gan Zang Bing Za Zhi","authors":["Ma, K","Chen, T","Han, M F","Guo, W","Ning, Q"],"date":"2020-03-04T11:00:00Z","year":2020,"_id":"32125126","week":"202010|Mar 02 - Mar 08","doi":"10.3760/cma.j.issn.1007-3418.2020.0002","keywords":["2019 novel coronavirus","Corona virus disease 2019","Diagnosis","Treatment"],"source":"PubMed","locations":["Wuhan","Hubei"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1663352134292209664,"score":198.61049},{"pmid":32170865,"title":"Coronavirus disease 2019: What we know?","text":["Coronavirus disease 2019: What we know?","In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the World Health Organization, respectively. The COVID-19 epidemic is spreading in China and all over the world now. The purpose of this review is primarily to review the pathogen, clinical features, diagnosis, and treatment of COVID-19, but also to comment briefly on the epidemiology and pathology based on the current evidence.","J Med Virol","He, Feng","Deng, Yu","Li, Weina","32170865"],"abstract":["In late December 2019, a cluster of unexplained pneumonia cases has been reported in Wuhan, China. A few days later, the causative agent of this mysterious pneumonia was identified as a novel coronavirus. This causative virus has been temporarily named as severe acute respiratory syndrome coronavirus 2 and the relevant infected disease has been named as coronavirus disease 2019 (COVID-19) by the World Health Organization, respectively. The COVID-19 epidemic is spreading in China and all over the world now. The purpose of this review is primarily to review the pathogen, clinical features, diagnosis, and treatment of COVID-19, but also to comment briefly on the epidemiology and pathology based on the current evidence."],"journal":"J Med Virol","authors":["He, Feng","Deng, Yu","Li, Weina"],"date":"2020-03-15T11:00:00Z","year":2020,"_id":"32170865","week":"202011|Mar 09 - Mar 15","doi":"10.1002/jmv.25766","keywords":["COVID-19","SARS-CoV-2","coronavirus"],"source":"PubMed","locations":["Wuhan","China"],"countries":["China"],"countries_codes":["CHN|China"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1663352133967151104,"score":187.98233}]}